144 related articles for article (PubMed ID: 28544619)
1. Design and synthesis of some acridine-piperazine hybrids for the improvement of cognitive dysfunction.
Sharma A; Piplani P
Chem Biol Drug Des; 2017 Nov; 90(5):926-935. PubMed ID: 28544619
[TBL] [Abstract][Full Text] [Related]
2. Ameliorative effects of amide derivatives of 1,3,4-thiadiazoles on scopolamine induced cognitive dysfunction.
Kulshreshtha A; Piplani P
Eur J Med Chem; 2016 Oct; 122():557-573. PubMed ID: 27448914
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis and Molecular Docking Studies of New Potential Piperazine Derivatives as Cognition Enhancers.
Danta CC; Piplani P
Cent Nerv Syst Agents Med Chem; 2017; 17(2):157-170. PubMed ID: 27758699
[TBL] [Abstract][Full Text] [Related]
4. Design and synthesis of newer potential 4-(N-acetylamino)phenol derived piperazine derivatives as potential cognition enhancers.
Piplani P; Danta CC
Bioorg Chem; 2015 Jun; 60():64-73. PubMed ID: 25965977
[TBL] [Abstract][Full Text] [Related]
5. Coumarin derivatives as potential inhibitors of acetylcholinesterase: Synthesis, molecular docking and biological studies.
Singla S; Piplani P
Bioorg Med Chem; 2016 Oct; 24(19):4587-4599. PubMed ID: 27519464
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking and Cognitive Impairment Attenuating Effect of Phenolic Compound Rich Fraction of Trianthema portulacastrum in Scopolamine Induced Alzheimer's Disease Like Condition.
Yadav E; Singh D; Debnath B; Rathee P; Yadav P; Verma A
Neurochem Res; 2019 Jul; 44(7):1665-1677. PubMed ID: 30949934
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and pharmacological evaluation of some novel indanone derivatives as acetylcholinesterase inhibitors for the management of cognitive dysfunction.
Piplani P; Jain A; Devi D; Anjali ; Sharma A; Silakari P
Bioorg Med Chem; 2018 Jan; 26(1):215-224. PubMed ID: 29195794
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, in vitro acetylcholinesterase inhibitory activity and molecular docking of new acridine-coumarin hybrids.
Hamulakova S; Janovec L; Soukup O; Jun D; Kuca K
Int J Biol Macromol; 2017 Nov; 104(Pt A):333-338. PubMed ID: 28601645
[TBL] [Abstract][Full Text] [Related]
9. Biphenyl-3-oxo-1,2,4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory.
Tripathi PN; Srivastava P; Sharma P; Tripathi MK; Seth A; Tripathi A; Rai SN; Singh SP; Shrivastava SK
Bioorg Chem; 2019 Apr; 85():82-96. PubMed ID: 30605887
[TBL] [Abstract][Full Text] [Related]
10. Amelioration of neurodegeneration and cognitive impairment by Lemon oil in experimental model of Stressed mice.
Falls N; Singh D; Anwar F; Verma A; Kumar V
Biomed Pharmacother; 2018 Oct; 106():575-583. PubMed ID: 29990845
[TBL] [Abstract][Full Text] [Related]
11. Novel piperazine derivative PMS1339 exhibits tri-functional properties and cognitive improvement in mice.
Miezan Ezoulin JM; Shao BY; Xia Z; Xie Q; Li J; Cui YY; Wang H; Dong CZ; Zhao YX; Massicot F; Qiu ZB; Heymans F; Chen HZ
Int J Neuropsychopharmacol; 2009 Nov; 12(10):1409-19. PubMed ID: 19460190
[TBL] [Abstract][Full Text] [Related]
12. Systematic
Silakari P; Silakari O; Piplani P
ACS Chem Neurosci; 2021 May; 12(9):1648-1666. PubMed ID: 33852798
[TBL] [Abstract][Full Text] [Related]
13. Anti-amnesic effects of Ganoderma species: A possible cholinergic and antioxidant mechanism.
Kaur R; Singh V; Shri R
Biomed Pharmacother; 2017 Aug; 92():1055-1061. PubMed ID: 28618650
[TBL] [Abstract][Full Text] [Related]
14. Rational design and biological evaluation of a new class of thiazolopyridyl tetrahydroacridines as cholinesterase and GSK-3 dual inhibitors for Alzheimer's disease.
Jiang X; Zhou J; Wang Y; Chen L; Duan Y; Huang J; Liu C; Chen Y; Liu W; Sun H; Feng F; Qu W
Eur J Med Chem; 2020 Dec; 207():112751. PubMed ID: 32950908
[TBL] [Abstract][Full Text] [Related]
15. Novel tacrine/acridine anticholinesterase inhibitors with piperazine and thiourea linkers.
Hamulakova S; Imrich J; Janovec L; Kristian P; Danihel I; Holas O; Pohanka M; Böhm S; Kozurkova M; Kuca K
Int J Biol Macromol; 2014 Sep; 70():435-9. PubMed ID: 25036600
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of triazole-oxadiazole conjugates for the management of cognitive dysfunction.
Jain A; Piplani P
Bioorg Chem; 2020 Oct; 103():104151. PubMed ID: 32871346
[TBL] [Abstract][Full Text] [Related]
17. Substituted piperazines as nootropic agents: 2- or 3-phenyl derivatives structurally related to the cognition-enhancer DM235.
Guandalini L; Martino MV; Di Cesare Mannelli L; Bartolucci G; Melani F; Malik R; Dei S; Floriddia E; Manetti D; Orlandi F; Teodori E; Ghelardini C; Romanelli MN
Bioorg Med Chem Lett; 2015 Apr; 25(8):1700-1704. PubMed ID: 25813160
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and AChE inhibitory activity of new benzothiazole-piperazines.
Demir Özkay Ü; Can ÖD; Sağlık BN; Acar Çevik U; Levent S; Özkay Y; Ilgın S; Atlı Ö
Bioorg Med Chem Lett; 2016 Nov; 26(22):5387-5394. PubMed ID: 27789142
[TBL] [Abstract][Full Text] [Related]
19. Design and development of novel N-(pyrimidin-2-yl)-1,3,4-oxadiazole hybrids to treat cognitive dysfunctions.
Tripathi PN; Srivastava P; Sharma P; Seth A; Shrivastava SK
Bioorg Med Chem; 2019 Apr; 27(7):1327-1340. PubMed ID: 30795991
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of new thiazole-piperazines as acetylcholinesterase inhibitors.
Yurttaş L; Kaplancıklı ZA; Özkay Y
J Enzyme Inhib Med Chem; 2013 Oct; 28(5):1040-7. PubMed ID: 22871134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
